China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Exploring the mechanism of carvedilol in the treatment of liver cirrhosis using multiomics techniques'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131279
Registration Time: 2026/08/31
Type: Observational study
Primary Sponsor: Shandong Provincial Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340908
Published by HT Digital Content Services with permission from Health Daily Digest....